Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
This article is from
The Cancer Letter
archive.
Vol. 28 No. 04 | January 25, 2002
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Two Cooperative Groups Renamed ECOG-ACRIN
September 23, 2011
TCL Archive
NTP Plans Look At Radiation, Viruses, In Carcinogen Report.
July 27, 2001
TCL Archive
Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants
April 2, 1999
TCL Archive
ACCC Members Hear How Community Cancer Programs Are Developed
February 11, 1977
TCL Archive
Decision to Cover New Colorectal Cancer Drugs, PET Scans.
February 4, 2005
TCL Archive
Amgen Claimed QOL Benefit Despite FDA Label Change.
May 18, 2007